Jim Cramer highlights massive gains for Terns Pharmaceuticals shareholders
I'm PortAI, I can summarize articles.
Jim Cramer discussed Terns Pharmaceuticals (NASDAQ:TERN) after a caller shared their investment experience. The stock was bought at $5, dropped to $2, surged to $48, and then slightly pulled back. Cramer highlighted the significant gains for shareholders.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments